SIRPA and Alzheimer disease: To further elucidate the role of SIRPα-CD47 signal axis in AD pathology, we examined CD47 protein level in primary neuron subjected to Aβ stimulation and found that Aβo treatment significantly decreased CD47 expression (Supplementary Fig. 16a, b).